Kinome pathway activity assay by targeted mass spectrometry-based phosphoproteomics to enable personalized treatment of cancer with kinase inhibitors
Read MoreDec. 2014. CCA grant to built targeted MS-based kinome activity assay
- January 22, 2015
- Comments off